Compounds and methods for inhibiting the interaction of BCL proteins with binding partners

Details for Australian Patent Application No. 2005265131 (hide)

Owner Infinity Discovery, Inc.

Inventors Yu, Lin-Chen; Snyder, Daniel A.; Hafeez, Nafeeza; Depew, Kristopher M.; Grogan, Michael J.; Koney, Nii O.; Foley, Michael A.; Fritz, Christian C.; Marcaurelle, Lisa A.; Zhang, Linping; Hopkins, Brian T.; Castro, Alfredo C.; Mann, David A.; Holson, Edward B.; Deng, Wei; Wylie, Andrew A.; Liu, Tao; Underwood, Dennis J.; Georges Evangelinos, Asimina T.

Agent Griffith Hack

Pub. Number AU-B-2005265131

PCT Pub. Number WO2006/009869

Priority 60/659,301 07.03.05 US; 60/580,616 17.06.04 US

Filing date 17 June 2005

Wipo publication date 26 January 2006

Acceptance publication date 23 February 2012

International Classifications

C07D 261/02 (2006.01) Heterocyclic compounds having nitrogen and oxygen as the only ring hetero atoms

A61K 31/42 (2006.01) - Oxazoles

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

1 February 2007 PCT application entered the National Phase

  PCT publication WO2006/009869 Priority application(s): WO2006/009869

8 May 2008 Alteration of Name

  The name of the applicant has been altered to Infinity Discovery, Inc.

23 February 2012 Application Accepted

  Published as AU-B-2005265131

21 June 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005265142-Identifying virally infected and vaccinated organisms

2005265130-Filtering device with integral filter status indicator